Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

The global Adeno-Associated Virus (AAV) Gene Therapy market size is expected to reach $ 2966.6 million by 2029, rising at a market growth of 8.4% CAGR during the forecast period (2023-2029).

This report studies the global Adeno-Associated Virus (AAV) Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Adeno-Associated Virus (AAV) Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adeno-Associated Virus (AAV) Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Adeno-Associated Virus (AAV) Gene Therapy total market, 2018-2029, (USD Million)

Global Adeno-Associated Virus (AAV) Gene Therapy total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Adeno-Associated Virus (AAV) Gene Therapy total market, key domestic companies and share, (USD Million)

Global Adeno-Associated Virus (AAV) Gene Therapy revenue by player and market share 2018-2023, (USD Million)

Global Adeno-Associated Virus (AAV) Gene Therapy total market by Type, CAGR, 2018-2029, (USD Million)

Global Adeno-Associated Virus (AAV) Gene Therapy total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Adeno-Associated Virus (AAV) Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adeno-Associated Virus (AAV) Gene Therapy market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Adeno-Associated Virus (AAV) Gene Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Type
Luxturna
Zolgensma
Others

Global Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Application
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases

Companies Profiled:
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio

Key Questions Answered

1. How big is the global Adeno-Associated Virus (AAV) Gene Therapy market?

2. What is the demand of the global Adeno-Associated Virus (AAV) Gene Therapy market?

3. What is the year over year growth of the global Adeno-Associated Virus (AAV) Gene Therapy market?

4. What is the total value of the global Adeno-Associated Virus (AAV) Gene Therapy market?

5. Who are the major players in the global Adeno-Associated Virus (AAV) Gene Therapy market?

6. What are the growth factors driving the market demand?